Both M(2) and M(3) muscarinic receptors are expressed in smooth muscle and influence contraction through distinct signaling pathways. M(3) receptors interact with G(q) to trigger phosphoinositide hydrolysis, Ca(2+) mobilization and a direct contractile response. In contrast, M(2) receptors interact with G(i) and G(o) to inhibit adenylyl cyclase and Ca(2+)-activated K(+) channels and to potentiate a Ca(2+)-dependent, nonselective cation conductance. Ultimately, these mechanisms lead to the prediction that the influence of the M(2) receptor on contraction should be conditional upon mobilization of Ca(2+) by another receptor such as the M(3). Mathematical modeling studies of these mechanisms show that the competitive antagonism of a muscarinic response mediated through activation of both M(2) and M(3) receptors should resemble the profile of the directly acting receptor (i.e., the M(3)) and not that of the conditionally acting receptor (i.e., the M(2)). Using a combination of pharmacological and genetic approaches, we have identified two mechanisms for the M(2) receptor in contraction: 1) a high potency inhibition of the relaxation elicited by agents that increase cytosolic cAMP and 2) a low potency potentiation of contractions elicited by the M(3) receptor. The latter mechanism may be involved in muscarinic agonist-mediated heterologous desensitization of smooth muscle, which requires activation of both M(2) and M(3) receptors.
Ehlert FJ. Ehlert FJ. Recept Channels. 2003;9(4):261-77. Recept Channels. 2003. PMID: 12893538 Review.
Ehlert FJ, Griffin MT, Abe DM, Vo TH, Taketo MM, Manabe T, Matsui M. Ehlert FJ, et al. J Pharmacol Exp Ther. 2005 Apr;313(1):368-78. doi: 10.1124/jpet.104.077909. Epub 2004 Dec 17. J Pharmacol Exp Ther. 2005. PMID: 15608083
Ehlert FJ, Sawyer GW, Esqueda EE. Ehlert FJ, et al. Life Sci. 1999;64(6-7):387-94. doi: 10.1016/s0024-3205(98)00584-0. Life Sci. 1999. PMID: 10069501 Review.
Ekman M, Andersson KE, Arner A. Ekman M, et al. BJU Int. 2009 Jan;103(1):90-7. doi: 10.1111/j.1464-410X.2008.07935.x. Epub 2008 Aug 22. BJU Int. 2009. PMID: 18727613
Kories C, Czyborra C, Fetscher C, Schneider T, Krege S, Michel MC. Kories C, et al. Naunyn Schmiedebergs Arch Pharmacol. 2003 May;367(5):524-31. doi: 10.1007/s00210-003-0713-8. Epub 2003 Mar 28. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12669188
Mahapatra C, Thakkar R. Mahapatra C, et al. Int J Mol Sci. 2024 Jun 22;25(13):6875. doi: 10.3390/ijms25136875. Int J Mol Sci. 2024. PMID: 38999984 Free PMC article.
Amrani O, Karim A, Marghich M, Beyi L, Bouknana S, Aziz M. Amrani O, et al. J Smooth Muscle Res. 2024;60:10-22. doi: 10.1540/jsmr.60.10. J Smooth Muscle Res. 2024. PMID: 38777767 Free PMC article.
Flores-Flores A, Estrada-Soto S, Millán-Pacheco C, Bazán-Perkins B, Hernández-Pando R, Ibarra-Barajas M, Villalobos-Molina R. Flores-Flores A, et al. Biomedicines. 2023 Jun 30;11(7):1870. doi: 10.3390/biomedicines11071870. Biomedicines. 2023. PMID: 37509509 Free PMC article.
Alkawadri T, McGarvey LP, Mullins ND, Hollywood MA, Thornbury KD, Sergeant GP. Alkawadri T, et al. Function (Oxf). 2021 Oct 20;3(1):zqab053. doi: 10.1093/function/zqab053. eCollection 2022. Function (Oxf). 2021. PMID: 35330928 Free PMC article.
Marghich M, Amrani O, Mekhfi H, Ziyyat A, Bnouham M, Aziz M. Marghich M, et al. J Smooth Muscle Res. 2021;57(0):35-48. doi: 10.1540/jsmr.57.35. J Smooth Muscle Res. 2021. PMID: 34545006 Free PMC article.